Loading...
Nyrada Inc.
NYR.AX•ASX
Healthcare
Biotechnology
A$0.37
A$0.00(0.00%)
Nyrada Inc. (NYR.AX) Financial Performance & Income Statement Overview
Review Nyrada Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
50.16%
↑ 50.16%
Net Income Growth
82.26%
↑ 82.26%
Operating Cash Flow Growth
89.44%
↑ 89.44%
Operating Margin
-831.02%
↓ 831.02%
Gross Margin
-127.07%
↓ 127.07%
Net Profit Margin
-499.49%
↓ 499.49%
ROE
-73.05%
↓ 73.05%
ROIC
-112.72%
↓ 112.72%
Nyrada Inc. (NYR.AX) Income Statement & Financial Overview
Review Nyrada Inc.'s (NYR.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $2.46M | $474468.00 | $955437.00 |
| Cost of Revenue | $2321.00 | $2841.00 | $3204.00 | $3358.00 |
| Gross Profit | -$2321.00 | $2.45M | $471263.00 | $952078.00 |
| Gross Profit Ratio | $0.00 | $1.00 | $0.99 | $1.00 |
| R&D Expenses | $1.14M | $888654.00 | $4.24M | $2.20M |
| SG&A Expenses | $1.12M | $1.41M | $1.17M | $1.53M |
| Operating Expenses | $2.26M | $2.30M | $5.41M | $3.74M |
| Total Costs & Expenses | $2.26M | $2.30M | $5.42M | $3.74M |
| Interest Income | $0.00 | $0.00 | $148817.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2321.00 | $2841.00 | $3204.00 | $3358.00 |
| EBITDA | -$2.36M | -$2.23M | -$5.69M | -$3.56M |
| EBITDA Ratio | $0.00 | -$0.94 | -$11.41 | -$3.91 |
| Operating Income | -$2.26M | -$2.30M | -$5.42M | -$3.74M |
| Operating Income Ratio | $0.00 | -$0.94 | -$11.42 | -$3.91 |
| Other Income/Expenses (Net) | -$107227.00 | $65474.00 | -$280374.00 | $176657.00 |
| Income Before Tax | -$2.36M | -$2.24M | -$5.70M | -$3.56M |
| Income Before Tax Ratio | $0.00 | -$0.91 | -$12.008 | -$3.73 |
| Income Tax Expense | -$836344.00 | -$2.37M | -$543036.00 | -$892185.00 |
| Net Income | -$1.53M | $135299.00 | -$5.15M | -$2.67M |
| Net Income Ratio | $0.00 | $0.06 | -$10.86 | -$2.79 |
| EPS | -$0.009 | $0.001 | -$0.03 | -$0.02 |
| Diluted EPS | -$0.009 | $0.001 | -$0.03 | -$0.02 |
| Weighted Avg Shares Outstanding | $162.36M | $156.009M | $156.009M | $156.009M |
| Weighted Avg Shares Outstanding (Diluted) | $162.36M | $170.45M | $156.009M | $156.009M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan